629 results
Page 2 of 32
8-K
EX-1.1
ob9stp1
24 Apr 23
Entry into a Material Definitive Agreement
4:40pm
424B4
w2g9u30q6lfo3op8mt71
20 Apr 23
Prospectus supplement with pricing info
6:03pm
8-K
uhlzpe2
6 Apr 23
Results of Operations and Financial Condition
7:58pm
8-K
EX-99.1
avqae
3 Apr 23
Windtree Therapeutics Reports Fourth Quarter and Year-End 2022 Financial Results and Provides Key Business Updates
7:25am
8-K
EX-99.1
ge2a93r6ypqn1ti10k
5 Dec 22
Other Events
7:48am
8-K
EX-99.1
49zeg5f
14 Nov 22
Windtree Therapeutics Reports Third Quarter 2022 Financial Results and Provides Key Business Updates
7:33am
8-K
EX-99.1
2bz1rn
23 Aug 22
Windtree Therapeutics Announces KL4 Surfactant and AEROSURF® Global License Agreement
8:30am
8-K
EX-99.1
e6mhtma
11 Aug 22
Windtree Therapeutics Reports Second Quarter 2022 Financial Results and Provides Key Business Updates
4:06pm
8-K
EX-99.1
1mee3dkziqvn 0ar
23 May 22
The study met its primary endpoint of improved systolic blood pressure (SBP) profile at 6 hours
4:01pm
8-K
EX-99.1
q82256w
5 May 22
Windtree Therapeutics Reports First Quarter 2022 Financial Results and Provides Key Business Updates
4:04pm